| 1 | our sponsors our sponsors | | | | | | 2 | 0.70% |
| 2 | skip to main content | | | | | | | 1 | 0.35% |
| 3 | webinar zoom august 13 | | | | | | | 1 | 0.35% |
| 4 | 3 2024 4th dcvmn | | | | | | | 1 | 0.35% |
| 5 | 2024 4th dcvmn techtransfer | | | | | | | 1 | 0.35% |
| 6 | 4th dcvmn techtransfer training | | | | | | | 1 | 0.35% |
| 7 | dcvmn techtransfer training dcvmn | | | | | | | 1 | 0.35% |
| 8 | achievements workforce training upcoming | | | | | | | 1 | 0.35% |
| 9 | workforce training upcoming eventssee | | | | | | | 1 | 0.35% |
| 10 | training upcoming eventssee all | | | | | | | 1 | 0.35% |
| 11 | upcoming eventssee all july | | | | | | | 1 | 0.35% |
| 12 | eventssee all july 15 | | | | | | | 1 | 0.35% |
| 13 | all july 15 2024 | | | | | | | 1 | 0.35% |
| 14 | rommelag webinar zoom august | | | | | | | 1 | 0.35% |
| 15 | zoom august 13 2024 | | | | | | | 1 | 0.35% |
| 16 | weconnecttoprotect june 3 2024 | | | | | | | 1 | 0.35% |
| 17 | august 13 2024 sunflower | | | | | | | 1 | 0.35% |
| 18 | 13 2024 sunflower therapeutics | | | | | | | 1 | 0.35% |
| 19 | 2024 sunflower therapeutics webinar | | | | | | | 1 | 0.35% |
| 20 | – benefits of using | | | | | | | 1 | 0.35% |
| 21 | benefits of using pichia | | | | | | | 1 | 0.35% |
| 22 | of using pichia pastoris | | | | | | | 1 | 0.35% |
| 23 | using pichia pastoris as | | | | | | | 1 | 0.35% |
| 24 | pichia pastoris as a | | | | | | | 1 | 0.35% |
| 25 | pastoris as a host | | | | | | | 1 | 0.35% |
| 26 | as a host for | | | | | | | 1 | 0.35% |
| 27 | a host for vaccine | | | | | | | 1 | 0.35% |
| 28 | manufacturing zoom september 2426 | | | | | | | 1 | 0.35% |
| 29 | june 3 2024 4th | | | | | | | 1 | 0.35% |
| 30 | annual report dcvmn achievements | | | | | | | 1 | 0.35% |
| 31 | september 2426 2024 strategic | | | | | | | 1 | 0.35% |
| 32 | latest newssee all june | | | | | | | 1 | 0.35% |
| 33 | are developing vaccines against | | | | | | | 1 | 0.35% |
| 34 | developing vaccines against covid19 | | | | | | | 1 | 0.35% |
| 35 | vaccines against covid19 0 | | | | | | | 1 | 0.35% |
| 36 | against covid19 0 of | | | | | | | 1 | 0.35% |
| 37 | covid19 0 of global | | | | | | | 1 | 0.35% |
| 38 | covid19 production so far | | | | | | | 1 | 0.35% |
| 39 | production so far contributed | | | | | | | 1 | 0.35% |
| 40 | so far contributed by | | | | | | | 1 | 0.35% |